Clinical trial
A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular…
NCT00471380 · Alcon Research, Industry · Completed
Key facts
| NCT number | NCT00471380 |
|---|---|
| Title | A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension |
| Official title | A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension |
| Lead sponsor | Alcon Research, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Glaucoma, Ocular Hypertension |
| Intervention type | Drug |
| Interventions | travoprost 0.004% and brinzolamide 1%, fixed combination of timolol 0.5% and dorzolamide 2% plus travoprost vehicle |
| Enrollment | 46 |
| Start date | Mar 1, 2007 |
| Primary completion | Oct 1, 2008 |
| First posted | May 9, 2007 |
| Last update posted | Mar 16, 2010 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: